253 related articles for article (PubMed ID: 11433642)
1. Post-kala-azar dermal leishmaniasis manifesting after initiation of highly active anti-retroviral therapy in a patient with human immunodeficiency virus infection.
Gilad J; Borer A; Hallel-Halevy D; Riesenberg K; Alkan M; Schlaeffer F
Isr Med Assoc J; 2001 Jun; 3(6):451-2. PubMed ID: 11433642
[No Abstract] [Full Text] [Related]
2. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
Karki P; Koirala S; Parija SC; Sethi M; Das ML
Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
[TBL] [Abstract][Full Text] [Related]
3. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation.
Rijal A; Agrawal S; Agarwalla A; Agrawal A; Rijal S
Int J Dermatol; 2005 Jun; 44(6):494-6. PubMed ID: 15941439
[No Abstract] [Full Text] [Related]
4. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
[TBL] [Abstract][Full Text] [Related]
5. Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome.
Antinori S; Longhi E; Bestetti G; Piolini R; Acquaviva V; Foschi A; Trovati S; Parravicini C; Corbellino M; Meroni L
Br J Dermatol; 2007 Nov; 157(5):1032-6. PubMed ID: 17854365
[TBL] [Abstract][Full Text] [Related]
6. Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
Ramos A; Cruz I; Muñez E; Salas C; Fernández A; Alvarez-Espejo T
Infection; 2008 Mar; 36(2):184-6. PubMed ID: 18327683
[No Abstract] [Full Text] [Related]
7. Combination of sodium stibogluconate and rifampicin in post kala-azar dermal leishmaniasis.
Sharma VK; Prasad HR; Sethuraman G; Khaitan BK
Indian J Dermatol Venereol Leprol; 2007; 73(1):53-4. PubMed ID: 17314452
[No Abstract] [Full Text] [Related]
8. Leishmaniasis (PKDL) as a case of immune reconstitution inflammatory syndrome (IRIS) in HIV-positive patient after initiation of anti-retroviral therapy (ART).
Tadesse A; Hurissa Z
Ethiop Med J; 2009 Jan; 47(1):77-9. PubMed ID: 19743785
[TBL] [Abstract][Full Text] [Related]
9. Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine.
Kumar D; Ramesh V; Verma S; Ramam M; Salotra P
Ann Trop Med Parasitol; 2009 Dec; 103(8):727-30. PubMed ID: 20030997
[No Abstract] [Full Text] [Related]
10. Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.
Sundar S; Kumar K; Chakravarty J; Agrawal D; Agrawal S; Chhabra A; Singh V
Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):698-700. PubMed ID: 16325873
[TBL] [Abstract][Full Text] [Related]
11. Post-kala-azar dermal leishmaniasis--an unusual presentation.
Lakhanpal S; Pandhi RK; Khaitan BK
Acta Derm Venereol; 1998 Sep; 78(5):353-4. PubMed ID: 9779253
[TBL] [Abstract][Full Text] [Related]
12. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
[TBL] [Abstract][Full Text] [Related]
13. Blindness following visceral leishmaniasis: a neglected post-kala-azar complication.
Khalil EA; Musa AM; Younis BM; Elfaki ME; Zijlstra EE; Elhassan AM
Trop Doct; 2011 Jul; 41(3):139-40. PubMed ID: 21676981
[TBL] [Abstract][Full Text] [Related]
14. Post kala-azar dermal leishmaniasis: the Kenyan experience.
Muigai R; Gachihi GS; Oster CN; Were JB; Nyakundi PM; Chunge CN; Kirigi G; Rashid JR
East Afr Med J; 1991 Oct; 68(10):801-6. PubMed ID: 1667521
[TBL] [Abstract][Full Text] [Related]
15. A case of Post-kala-azar dermal leishmaniasis.
Ono H; Ghoreishi M; Yokozeki H; Katayama I; Nishioka K
J Dermatol; 1998 Feb; 25(2):118-20. PubMed ID: 9563280
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity reaction over lesions of post-kala-azar dermal leishmaniasis mimicking type 1 reaction in leprosy.
Dhar S; Malakar S
Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):66-7. PubMed ID: 10407631
[No Abstract] [Full Text] [Related]
17. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.
Gelanew T; Amogne W; Abebe T; Kuhls K; Hailu A; Schönian G
Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449
[TBL] [Abstract][Full Text] [Related]
18. Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum.
Ridolfo AL; Gervasoni C; Antinori S; Pizzuto M; Santambrogio S; Trabattoni D; Clerici M; Galli M
J Infect; 2000 Mar; 40(2):199-202. PubMed ID: 10841104
[TBL] [Abstract][Full Text] [Related]
19. Verrucous papillomatous lesion of post-kala-azar dermal leishmaniasis: fine needle aspiration diagnosis of an unusual presentation.
Bhadani PP; Sen R; Singh RK
Acta Cytol; 2007; 51(2):252-4. PubMed ID: 17425218
[No Abstract] [Full Text] [Related]
20. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]